Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9+ tumors

Overview of attention for article published in Frontiers in immunology, July 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 9 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

COMBINATION THERAPY COMPRISING ANTI-CCR9 ANTIBODY AND VINCRISTINE FOR CANCER

Application WO-2023148346-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.